Premium
Aztreonam and ceftazidime: evidence of in vivo cross‐allergenicity
Author(s) -
Pimiento A. Pérez,
Gómez Martínez M.,
Mínguez Mena A.,
Trampal González A.,
Paz Arranz S.,
Rodríguez Mosquera M.
Publication year - 1998
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1998.tb03944.x
Subject(s) - medicine , humanities , art
REFERENCES 1. Szczeklik A. Adverse reactions to aspirin and nonsteroidal antiinflammatory drugs. Ann Allergy 1987;59:113-18. 2. Alkhawajah AM, Eifawai M, Mahmoud SF Fatal anaphyiactic reaction to diclofenac. Forensic Sci Int 1993;60:107-10. 3. Mescheder A, Nokhodian A, Kirch W. Anaphylactic shock as complication of Ml application of diclofenac. Arzneimitteltherapie 1993;11:237-9. 4. Romano A, Pietrantonio f̂ Di Fonso M, et al. Positivity of patch tests in cutaneous reaction to diclofenac. Allergy 1994;49.57-9. 5. Gebhardt M, Reuter A, Knopf B. Allergic contact dermatitis from topical diclofenac. Contact Dermatitis 1994;30:183-4. 6. Faich G. Special report: adverse drug reaction monitoring. N Engl J Med 1986;314:1589-92. 7 Stevenson D. Diagnosis, prevention and treatment of adverse reactions to aspirin and nonsteroidal antiinflammatory drugs. J Allergy Clin Immunol 1984;74:617-22. NH2 Aztreonam